Supriya Lifescience Ltd.
NSE: SUPRIYA | BSE: 543434
₹874.90
₹13.20
(1.53%)
As on 09-Jul-2026IST
Market cap
₹7,045 Cr
Revenue (TTM)
₹828 Cr
P/E Ratio
33.7
P/B Ratio
5.9
Div. Yield
0.1 %
Quality Score
9/10
Growth Score
8/10
Valuation Score
3/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹209 Cr
-
ROE
20.7 %
-
ROCE
27.6 %
-
Industry P/E
36.64
-
EV/EBITDA
22.8
-
Debt to Equity
0
-
Book Value
₹148.8
-
EPS
₹26
-
Face value
2
-
Shares outstanding
80,482,800
10 Years Aggregate
CFO
₹699.78 Cr
EBITDA
₹1,173.75 Cr
Net Profit
₹805.24 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
| 16.4 | -4.8 | 37.4 | 24.2 | 52.8 | -- | -- |
|
BSE Healthcare
| 14.7 | 6.3 | 18.3 | 11.9 | 24.3 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Supriya Lifescience
| -0.7 | 135.0 | 33.9 | -51.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
874.9 | 7,045.1 | 827.9 | 209.1 | 32.1 | 18.4 | 33.7 | 5.9 |
| 8,114.5 | 20,278.4 | 2,275.6 | 187.5 | 10.3 | 22.9 | 108.1 | 23.2 | |
| 2,621.4 | 19,918.1 | 2,187.2 | 649.7 | 31.5 | 19 | 31.1 | 5.6 | |
| 2,022.8 | 12,347.9 | 1,403.2 | 185.1 | -- | 27.4 | 66.7 | 16.5 | |
| 1,430.0 | 19,836.1 | 3,129.4 | 647.4 | 26.9 | 18.1 | 32 | 5.1 | |
| 2,444.5 | 39,191.6 | 4,147.8 | 709.5 | 22.3 | 19.1 | 55.2 | 9.4 | |
| 4,590.1 | 21,046.2 | 2,519.7 | 722.4 | 33.6 | 17.2 | 29.1 | 5.0 | |
| 6,612.0 | 10,992.1 | 1,408.0 | 326.9 | 30.8 | 57.1 | 33.6 | 21.0 | |
| 622.3 | 12,147.6 | 1,538.1 | 226.2 | 20.4 | 9 | 49.9 | 4.7 | |
| 1,076.0 | 9,898.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 17.8 | 3.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Supriya Lifescience IPO: How good is it?
5 min read•By Udhayaprakash and Karthik Anand Vijay
Supriya Lifescience IPO: Information analysis
3 min read•By Udhayaprakash and Karthik Anand Vijay
About Supriya Lifescience
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic,... decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India. Read more
-
Incorporated
2008
-
Chairman
Satish Waman Wagh
-
Managing Director
Saloni Satish Wagh
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Supriya Lifescience Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Supriya Lifescience
What is the current share price of Supriya Lifescience Ltd Today?
The share price of Supriya Lifescience Ltd is ₹874.90 (NSE) and ₹875.35 (BSE) as of 09-Jul-2026 IST. Supriya Lifescience Ltd has given a return of 52.85% in the last 3 years.
What is the current PB & PE ratio of Supriya Lifescience Ltd?
The P/E ratio of Supriya Lifescience Ltd is 33.69 times as on 09-Jul-2026, a 8 discount to its peers’ median range of 36.64 times.
The P/B ratio of Supriya Lifescience Ltd is 5.88 times as on 09-Jul-2026, a 15 premium to its peers’ median range of 5.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
31.41
|
5.92
|
|
2024
|
22.42
|
3.27
|
|
2023
|
17.08
|
2.19
|
|
2022
|
26.13
|
6.44
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Supriya Lifescience Ltd?
The 52-week high and low of Supriya Lifescience Ltd are Rs 1,085.00 and Rs 545.50 as of 10-Jul-2026.
What is the market cap of Supriya Lifescience Ltd?
Supriya Lifescience Ltd has a market capitalisation of ₹ 7,045 Cr as on 09-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Supriya Lifescience Ltd?
Before investing in Supriya Lifescience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.